Vanguard Group
TSVT

Vanguard Group’s 2seventy bio TSVT Stock Holding History

Vanguard Group’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,819,469
Closed -$13.9M – 4326
2025
Q1 		$13.9M Sell
2,819,469
-941,776
-25% -$2.99M ﹤0.01% 2668
2024
Q4 		$11.1M Sell
3,761,245
-10,987
-0.3% -$45.1K ﹤0.01% 2899
2024
Q3 		$17.8M Buy
3,772,232
+143,111
+4% +$645K ﹤0.01% 2645
2024
Q2 		$14M Sell
3,629,121
-102,558
-3% -$462K ﹤0.01% 2738
2024
Q1 		$20M Sell
3,731,679
-254,091
-6% -$1.2M ﹤0.01% 2597
2023
Q4 		$17M Buy
3,985,770
+251,893
+7% +$774K ﹤0.01% 2669
2023
Q3 		$14.6M Buy
3,733,877
+256,203
+7% +$1.68M ﹤0.01% 2682
2023
Q2 		$35.2M Buy
3,477,674
+573,640
+20% +$6.07M ﹤0.01% 2350
2023
Q1 		$29.6M Buy
2,904,034
+499,805
+21% +$5.71M ﹤0.01% 2420
2022
Q4 		$22.5M Buy
2,404,229
+48,296
+2% +$681K ﹤0.01% 2562
2022
Q3 		$34.3M Buy
2,355,933
+25,850
+1% +$384K ﹤0.01% 2368
2022
Q2 		$30.8M Buy
2,330,083
+949,757
+69% +$12.9M ﹤0.01% 2425
2022
Q1 		$23.5M Sell
1,380,326
-479,623
-26% -$8.14M ﹤0.01% 2676
2021
Q4 		$47.7M Buy
+1,859,949
New +$58M ﹤0.01% 2380

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Vanguard Group's TSVT Position: Q2 2025 in Review

Vanguard Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 2,819,469 shares — an estimated $13.9M sold.

Vanguard Group first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $47.7M in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Vanguard Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Vanguard Group sold 2,819,469 2seventy bio shares in Q2 2025, an estimated $13.9M.
  • Vanguard Group first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Vanguard Group's 2seventy bio position peaked at $47.7M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.